hrp0094yb1.4 | Year of Paediatric Endocrinology 1 | ESPE2021
, Inzaghi Elena
, Pampanini Valentina
, Fintini Danilo
Long-term safety of rhGH therapy in childhood has been object of intense investigation in the last decade. Two recent observational studies have focused on the risk of cardiovascular diseases in young adults treated with rhGH during childhood. After subdividing the large cohorts of patients in different risk groups they found that both mortality and morbidity from cardiovascular diseases were higher than the general population in the low risk group including patients with isol...